High-affinity partial agonists of the vanilloid receptor

Molecular Pharmacology

Volumn 64, Issue 2, 2003, Pages 325-333

  Wang, Yun ^a,c   Toth, Attila ^d   Tran, Richard ^a   Szabo, Tamas ^a   Welter, Jacqueline D ^a   Blumberg, Peter M ^a   Lee, Jiyoun ^b   Kang, Sang Uk ^b   Lim, Ju Ok ^b   Lee, Jeewoo ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Seoul National University   (South Korea)

^c PEKING UNIVERSITY   (China)

^d MSC 4255 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; JYL 1511; JYL 827; N (4 TERT BUTYLBENZYL) N' [3 METHOXY 4 (METHYLSULFONYLAMINO)BENZYL]THIOUREA; N [2 (3,4 DIMETHYLBENZYL) 3 (PIVALOYLOXY)PROPYL] N' [4 (METHYLSULFONYLAMINO)BENZYL]THIOUREA; PROTON; RESINIFERATOXIN; TETRACYCLINE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR AGONIST;

ANIMAL CELL; ARTICLE; BLADDER FUNCTION; CHO CELL; CHRONIC PAIN; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG USE; HEAT; HUMAN; HYPERREFLEXIA; IC 50; INHIBITION KINETICS; LIGAND BINDING; MICTURITION REFLEX; NEUROMODULATION; NOCICEPTION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTON TRANSPORT; RAT; RECEPTOR AFFINITY; TEMPERATURE MEASUREMENT;

ANIMALS; CALCIUM; CHO CELLS; CRICETINAE; DRUG SYNERGISM; FEMALE; PROTEIN KINASE C; PROTONS; RATS; RECEPTORS, DRUG; SIGNAL TRANSDUCTION; SULFONAMIDES; TEMPERATURE; THIOUREA;

EID: 0037900092     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.2.325     Document Type: Article

References (31)

1. Bevan S, Hothi S, Hughes G, James IF, Rang HP, Shah K, Walpole CS, and Yeats JC (1992) Capsazepine: a competitive antagonist of the sensory neuron excitant capsaicin. Br J Pharmacol 107:544-552.
2. Crandall M, Kwash J, Yu W, and White G (2002) Activation of protein kinase C sensitizes human VR1 to capsaicin and to moderate decreases in pH at physiological temperatures in Xenopus oocytes. Pain 98:109-117.
3. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, and Di Marzo V (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 276:12856-12863.
4. Docherty RJ, Yeats JC, and Piper AS (1997) Capsazepine block of voltage-gated calcium channels in adult rat dorsal root ganglion neurons in culture. Br J Pharmacol 121:1461-1467.
5. Julius D and Basbaum AI (2001) Molecular mechanisms of nociception. Nature (Lond) 413:203-210.
6. Jung J, Hwang SW, Kwak J, Lee SY, Kang CT, Kim WB, Kim D, and Oh U (1999) Capsaicin binds to the intracellular domain of the capsaicin activated ion channel. J Neurosci 19:529-538.
7. Kenakin T (1997) Protean agonists. Keys to receptor active states? Ann NY Acad Sci 812:116-125.
8. Lee J, Lee J, Kang MS, Kim KP, Chung SJ, Blumberg PM, Yi JB, and Park YH (2002) Phenolic modification as an approach to improve the pharmacology of the 3-acyloxy-2-benzylpropyl homovanillic amides and thioureas, a promising class of vanilloid receptor agonists and analgesics. Bioorg Med Chem 10:1171-1179.
9. Lee J, Lee J, Kim J, Kim SY, Chun MW, Cho H, Hwang SW, Oh U, Park YH, Marquez VE, Beheshti M, Szabo T and Blumberg PM (2001a) N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics. Bioorg Med Chem 9:19-32.
10. Lee J, Lee J, Szabo T, Gonzalez AF, Welter JD, and Blumberg PM (2001b) N-(3-acyloxy-2-benzylpropyl)-N′-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline thiourea analogues as vanilloid receptor ligands. Bioorg Med Chem 9:1713-1720.
11. Lee J, Park SU, Kim JY, Kim JK, Lee J, Oh U, Marquez VE, Beheshti M, Wang QJ, Modarres S, and Blumberg PM (1999) 3-Acyloxy-2-phenalkylpropyl amides and esters of homovanillic acid as novel vanilloid receptor agonists. Bioorg Med Chem Lett 9:2909-2914.
12. Liu L, Lo Y, Chen I, and Simon SA (1997) The responses of rat trigeminal ganglion neurons to capsaicin and two nonpungent vanilloid receptor agonists, olvanil and glyceryl nonamide. J Neurosci 17:4101-4111.
13. Liu L and Simon SA (1997) Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine-receptors in rat trigeminal ganglia. Neurosci Lett 228:29-32.
14. McDonnell ME, Zhang SP, Dubin AE, and Dax SL (2002) Synthesis and in vitro evaluation of a novel iodinated resiniferatoxin derivative that is an agonist at the human vanilloid VR1 receptor. Bioorg Med Chem Lett 12:1189-1192.
15. Robbins W (2000) Clinical applications of capsaicinoids. Clin J Pain 16(Suppl 2): S86-S92.
16. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, and Davis JB (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129:227-230.
17. Suh YG, Oh UT, Kim HD, Lee JW, Park HG, Park OH, Lee YS, Park YH, Joo YH, Choi JK, et al. (2002a) investors; Pacific Corporation, assignee. Novel thiourea derivatives and the pharmaceutical compositions containing the same. International patent WO 02/16318 A1. 2002 Feb 28.
18. Suh YG, Oh UT, Kim HD, Lee JW, Park HG, Park YH, and Yi JB (2002b) investors; Pacific Corporation, assignee. Novel thiourea compounds and the pharmaceutical compositions containing the same. International patent WO 02/16319 A1. 2002 Feb 28.
19. Szallasi A (2001) Vanilloid receptor ligands: hopes and realities for the future. Drugs Aging 18:561-573.
20. Szallasi A and Blumberg PM (1989) Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 30:515-520.
21. Szallasi A and Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212.
22. Szallasi A, Blumberg PM, Annicelli LL, Krause JE, and Cortright DN (1999a) The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol Pharmacol 56:581-587.
23. Szallasi A, Szabo T, Biro T, Modarres S, Blumberg PM, Krause JE, Cortright DN, and Appendino G (1999b) Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1. Br J Pharmacol 128:428-434.
24. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, and Julius D (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531-543.
25. Vellani V, Mapplebeck S, Moriondo A, Davis JB, and McNaughton PA (2001) Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol 534:813-825.
26. Wahl P, Foged C, Tultin S, and Thomsen C (2001) Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol Pharmacol 59:9-15.
27. Walpole CSJ and Wrigglesworth R (1993). Structural requirements for capsaicin agonists and antagonists. In: Capsaicin in the Study of Pain (Wood J ed), pp 63-81, Academic Press, London.
28. Wang Y, Szabo T, Welter JD, Toth A, Tran R, Lee J, Kang U, Suh YG, Blumberg PM, and Lee J (2002) High-affinity antagonists of the vanilloid receptor [published erratum appears in Mol Pharmacol 63:958, 2003]. Mol Pharmacol 62:947-956.
29. Wardle KA, Ranson J, and Sanger GJ (1997) Pharmacological characterization of the vanilloid receptor in the rat dorsal spinal cord. Br J Pharmacol 121:1012-1016.
30. Wrigglesworth R, Walpole CSJ, Bevan S, Campbell EA, Dray A, Hughes GA, James I, Masdin KJ, and Winter J (1996) Analogues of capsaicin with agonist activity as novel analgesic agents: structure-activity studies. 4. Potent, orally active analgesics. J Med Chem 39:4942-4951.
31. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, and Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (Lond) 400:452-457.